News

Teva introduces psoriasis drug

BY Alaric DeArment

NORTH WALES, Pa. — Drug maker Teva Pharmaceutical Industries has introduced acitretin capsules, the company said.

Teva announced the availability of the capsules in the 10-mg, 17.5-mg and 25-mg strengths, in bottle sizes of 30.

The drug is a generic version of Soriatane and is used to treat psoriasis. Soriatane is made by Stiefel, a division of GlaxoSmithKline.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Sears offers ‘eCoupons’ for BTS

BY Alaric DeArment

HOFFMAN ESTATES, Ill. — Sears is offering electronic coupons for back-to-school shopping that it’s calling the first of their kind.

The retailer announced Monday that it was the first retailer to offer "eCoupons" that can be redeemed in the store, online and from a mobile device, personalized for members of the Shop Your Way loyalty program based on their interests, style preferences and shopping habits. Members can download the coupons at ShopYourWay.com or through the mobile app and receive rewards like 2% back in points when using their Sears MasterCard.

"No matter how or where our Shop Your Way members choose to shop with us during back-to-school season, Sears has a way to do so conveniently, save time and money and earn rewards," EVP and chief merchandising officer for the Sears and Kmart formats Ron Boire said. "We are creating experiences that make our Shop Your Way members come back for more — that’s why we expanded our apparel brands and in-store technology to appeal to the individual fashion and shopping styles of our members and customers."

Services include buying online and picking them up in the store, including having items delivered to their cars by texting their parking spot number to Sears; having items picked up by a different person; mobile checkout; and shipping to customers who can’t find desired items in the store.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA approves Astellas drug for preventing kidney rejection

BY Alaric DeArment

NORTHBROOK, Ill. — The Food and Drug Administration has approved a drug made by Japanese drug maker Astellas for preventing the body from rejecting transplanted organs, the company said.

Astellas announced through a U.S. subsidiary that the FDA had approved Astagraf XLTM (tacrolimus) extended-release capsules for preventing rejection of transplanted kidneys, for use with Genentech’s CellCept (mycophenolate mofetil) and corticosteroids, with or without Simulect (basiliximab), a biotech drug made by Swiss drug maker Novartis.

"Each transplant recipient is different and requires a personalized treatment approach," Astellas Pharma chief medical officer Sef Kurstjens said. "Astellas is pleased to continue our more than 20-year commitment to the field of transplant immunology."


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?